Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Crescent Capital BDC

DB:487
Snowflake Description

Very undervalued with high growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
487
DB
$268M
Market Cap
  1. Home
  2. DE
  3. Diversified Financials
Company description

Crescent Capital BDC, Inc. was incorporated in 2015 and is based in Los Angeles, California. The last earnings update was 29 days ago. More info.


Add to Portfolio Compare Print
  • Crescent Capital BDC is a fund or ETF! Currently our data availability for these is poor, we only recommend using them as part of a portfolio.
  • Crescent Capital BDC has significant price volatility in the past 3 months.
487 Share Price and Events
7 Day Returns
10.6%
DB:487
-6.8%
DE Capital Markets
-2.7%
DE Market
1 Year Returns
-
DB:487
-11.8%
DE Capital Markets
-20.4%
DE Market
487 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Crescent Capital BDC (487) 10.6% -37% - - - -
DE Capital Markets -6.8% -21.9% -18% -11.8% -29% -57.8%
DE Market -2.7% -18.4% -26.7% -20.4% -25.9% -30.4%
1 Year Return vs Industry and Market
  • No trading data on 487.
  • No trading data on 487.

487 Value

 Is Crescent Capital BDC undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Crescent Capital BDC to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Crescent Capital BDC.

DB:487 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Median Return on Equity from the past 5 years.
= Stable Book Value * Return on Equity
= $19.97 * 6.4%
$1.28
Book Value of Equity per Share Median Book Value from the past 5 years. $19.97
Discount Rate (Cost of Equity) See below 6.7%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:487
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Capital Markets Unlevered Beta Simply Wall St/ S&P Global 0.75
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.747 (1 + (1- 21%) (120.22%))
1.306
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.31
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (1.306 * 5.44%)
6.71%

Discounted Cash Flow Calculation for DB:487 using Excess Returns Model Model

The calculations below outline how an intrinsic value for Crescent Capital BDC is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

DB:487 Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (6.4% – 6.71%) * $19.97)
$-0.06
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= $-0.06 / (6.71% - -0.39%)
$-0.85
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= $19.97 + $-0.85
$19.11
DB:487 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:487 represents 0.93122x of NasdaqGM:CCAP
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.93122x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 19.11 x 0.93122
€17.80
Value per share (EUR) From above. €17.80
Current discount Discount to share price of €8.80
= -1 x (€8.80 - €17.80) / €17.80
50.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Crescent Capital BDC is available for.
Intrinsic value
>50%
Share price is €8.8 vs Future cash flow value of €17.8
Current Discount Checks
For Crescent Capital BDC to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Crescent Capital BDC's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Crescent Capital BDC's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Crescent Capital BDC's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Crescent Capital BDC's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:487 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $1.69
NasdaqGM:CCAP Share Price ** NasdaqGM (2020-04-02) in USD $9.45
Germany Capital Markets Industry PE Ratio Median Figure of 17 Publicly-Listed Capital Markets Companies 22.18x
Germany Market PE Ratio Median Figure of 401 Publicly-Listed Companies 16.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Crescent Capital BDC.

DB:487 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:CCAP Share Price ÷ EPS (both in USD)

= 9.45 ÷ 1.69

5.6x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Crescent Capital BDC is good value based on earnings compared to the DE Capital Markets industry average.
  • Crescent Capital BDC is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Crescent Capital BDC's expected growth come at a high price?
Raw Data
DB:487 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 5.6x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
27%per year
Germany Capital Markets Industry PEG Ratio Median Figure of 7 Publicly-Listed Capital Markets Companies 1.55x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.17x

*Line of best fit is calculated by linear regression .

DB:487 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 5.6x ÷ 27%

0.21x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Crescent Capital BDC is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Crescent Capital BDC's assets?
Raw Data
DB:487 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $19.50
NasdaqGM:CCAP Share Price * NasdaqGM (2020-04-02) in USD $9.45
Germany Capital Markets Industry PB Ratio Median Figure of 32 Publicly-Listed Capital Markets Companies 1.55x
Germany Market PB Ratio Median Figure of 572 Publicly-Listed Companies 1.44x
DB:487 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:CCAP Share Price ÷ Book Value per Share (both in USD)

= 9.45 ÷ 19.50

0.48x

* Primary Listing of Crescent Capital BDC.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Crescent Capital BDC is good value based on assets compared to the DE Capital Markets industry average.
X
Value checks
We assess Crescent Capital BDC's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. Crescent Capital BDC has a total score of 6/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

487 Future Performance

 How is Crescent Capital BDC expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
27%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Crescent Capital BDC expected to grow at an attractive rate?
  • Crescent Capital BDC's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Crescent Capital BDC's earnings growth is expected to exceed the Germany market average.
  • Crescent Capital BDC's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:487 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:487 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 27%
DB:487 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 25.4%
Germany Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 40%
Germany Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 0.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:487 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:487 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 91 6 53 1
2020-12-31 77 -323 48 1
2020-04-02
DB:487 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 53 -203 29
2019-09-30 49 -244 18
2019-06-30 43 -172 20
2019-03-31 38 -176 14
2018-12-31 33 -165 8
2018-09-30 29 -118 10
2018-06-30 27 -96 8
2018-03-31 25 -51 8
2017-12-31 22 -88 9
2017-09-30 21 -75 13
2017-06-30 18 -101 14
2017-03-31 16 -96 14

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Crescent Capital BDC's earnings are expected to grow significantly at over 20% yearly.
  • Crescent Capital BDC's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:487 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Crescent Capital BDC Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:487 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 2.03 2.03 2.03 1.00
2020-12-31 1.91 1.91 1.91 1.00
2020-04-02
DB:487 Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 1.69
2019-09-30 1.18
2019-06-30 1.50
2019-03-31 1.16
2018-12-31 0.76
2018-09-30 1.06
2018-06-30 0.88
2018-03-31 1.04
2017-12-31 1.20
2017-09-30 1.88
2017-06-30 2.18
2017-03-31 2.43

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Crescent Capital BDC is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Crescent Capital BDC's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Crescent Capital BDC has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

487 Past Performance

  How has Crescent Capital BDC performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Crescent Capital BDC's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Crescent Capital BDC has delivered over 20% year on year earnings growth in the past 5 years.
  • Crescent Capital BDC's 1-year earnings growth exceeds its 5-year average (260.8% vs 34.2%)
  • Crescent Capital BDC's earnings growth has exceeded the DE Capital Markets industry average in the past year (260.8% vs 5.7%).
Earnings and Revenue History
Crescent Capital BDC's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Crescent Capital BDC Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:487 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 53.48 29.28 8.29
2019-09-30 49.32 18.29 7.68
2019-06-30 43.21 20.37 7.21
2019-03-31 37.94 14.13 6.80
2018-12-31 33.30 8.11 7.00
2018-09-30 29.13 10.12 7.15
2018-06-30 26.60 7.67 7.39
2018-03-31 24.64 8.36 7.57
2017-12-31 22.29 9.06 7.06
2017-09-30 20.96 13.21 6.74
2017-06-30 18.23 14.07 5.95
2017-03-31 15.84 14.12 5.29
2016-12-31 13.89 11.77 4.77
2015-12-31 3.60 -2.35 1.91

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Crescent Capital BDC has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Crescent Capital BDC used its assets more efficiently than the DE Capital Markets industry average last year based on Return on Assets.
  • Crescent Capital BDC has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Crescent Capital BDC's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Crescent Capital BDC has a total score of 5/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

487 Health

 How is Crescent Capital BDC's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Crescent Capital BDC's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Crescent Capital BDC is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Crescent Capital BDC's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Crescent Capital BDC's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Crescent Capital BDC Company Filings, last reported 3 months ago.

DB:487 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 406.92 322.01 4.58
2019-09-30 380.82 319.49 18.08
2019-06-30 320.78 266.60 9.04
2019-03-31 288.65 233.51 11.99
2018-12-31 259.58 235.71 4.23
2018-09-30 231.59 202.64 12.33
2018-06-30 206.13 190.68 9.21
2018-03-31 187.66 144.22 9.42
2017-12-31 172.80 150.85 9.27
2017-09-30 165.26 137.89 7.79
2017-06-30 155.38 136.51 7.36
2017-03-31 144.58 125.64 7.59
2016-12-31 128.06 93.67 5.12
2015-12-31 77.59 54.49 4.77
  • Crescent Capital BDC's level of debt (79.1%) compared to net worth is high (greater than 40%).
  • Unable to establish if Crescent Capital BDC's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 3.4x coverage).
X
Financial health checks
We assess Crescent Capital BDC's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Crescent Capital BDC has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

487 Dividends

 What is Crescent Capital BDC's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
17.35%
Current annual income from Crescent Capital BDC dividends. Estimated to be 17.35% next year.
If you bought €2,000 of Crescent Capital BDC shares you are expected to receive €347 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Crescent Capital BDC's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.65%).
  • Crescent Capital BDC's dividend is above the markets top 25% of dividend payers in Germany (4.86%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:487 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Germany Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 3.3%
Germany Market Average Dividend Yield Market Cap Weighted Average of 320 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:487 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 1.64 1.00
2020-12-31 1.64 1.00
2020-04-02
DB:487 Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2020-03-04 1.640 16.471

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Crescent Capital BDC has stable dividend payments.
  • Crescent Capital BDC only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Crescent Capital BDC's earnings are paid to the shareholders as a dividend.
  • Dividends paid are not well covered by earnings (1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.2x coverage).
X
Income/ dividend checks
We assess Crescent Capital BDC's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Crescent Capital BDC afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Crescent Capital BDC has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

487 Management

 What is the CEO of Crescent Capital BDC's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jason Breaux
AGE 46
TENURE AS CEO 5.3 years
CEO Bio

Mr. Jason A. Breaux serves as the Chief Executive Officer at Crescent Capital BDC, Inc. Mr. Breaux serves as Senior Vice President of Special Situations at Senior Vice President of Special Situations. Mr. Breaux serves as an Assistant Vice President at WestBridge Ventures. He joined WestBridge in 2000. Before that, Mr. Breaux worked at Robertson Stephens performing mergers and acquisitions work for technology companies. Mr. Breaux served as a Financial Analyst at Salomon Brothers, where he specialized in various capital raising and strategic advisory assignments. He earned an M.B.A. from the Darden Graduate School of Business Administration at the University of Virginia and an A.B. from Georgetown University.

CEO Compensation
  • Insufficient data for Jason to compare compensation growth.
  • Insufficient data for Jason to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Crescent Capital BDC management team in years:

5.3
Average Tenure
48.5
Average Age
  • The average tenure for the Crescent Capital BDC management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Jason Breaux

TITLE
Chief Executive Officer
AGE
46
TENURE
5.3 yrs

Jonathan Insull

TITLE
President
AGE
54
TENURE
5.3 yrs

Gerhard Lombard

TITLE
CFO & Treasurer
AGE
45
TENURE
0.5 yrs

Joe Hanlon

TITLE
Chief Compliance Officer
AGE
51
TENURE
5.3 yrs

Raymond Barrios

TITLE
Managing Director
AGE
41
TENURE
3.3 yrs

George Hawley

TITLE
Secretary
AGE
51
TENURE
5.3 yrs

Kirill Bouek

TITLE
Controller
TENURE
0.1 yrs
Board of Directors Tenure

Average tenure and age of the Crescent Capital BDC board of directors in years:

5.3
Average Tenure
61
Average Age
  • The tenure for the Crescent Capital BDC board of directors is about average.
Board of Directors

John Bowman

TITLE
Chairman of the Board
AGE
60
TENURE
5.3 yrs

Steven Strandberg

TITLE
Independent Director
AGE
64
TENURE
5.3 yrs

Michael Segal

TITLE
Independent Director
AGE
62
TENURE
5.3 yrs

George Strong

TITLE
Independent Director
AGE
72
TENURE
5.3 yrs

Chris Wright

TITLE
Director
AGE
47
TENURE
5.3 yrs

Kathleen Briscoe

TITLE
Independent Director
AGE
59
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
03. Feb 20 Buy UFCW Employers Benefit Plans of Northern California Group Administration, LLC Company 30. Jan 20 30. Jan 20 343,178 €17.73 €6,084,675
X
Management checks
We assess Crescent Capital BDC's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Crescent Capital BDC has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

487 News

Simply Wall St News

487 Company Info

Description

Crescent Capital BDC, Inc. was incorporated in 2015 and is based in Los Angeles, California.

Details
Name: Crescent Capital BDC, Inc.
487
Exchange: DB
Founded: 2015
$244,940,309
28,342,930
Website: http://www.crescentbdc.com
Address: Crescent Capital BDC, Inc.
11100 Santa Monica Boulevard,
Suite 2000,
Los Angeles,
California, 90025,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM CCAP Common Stock Nasdaq Global Market US USD 03. Feb 2020
DB 487 Common Stock Deutsche Boerse AG DE EUR 03. Feb 2020
Number of employees
Current staff
Staff numbers
0
Crescent Capital BDC employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/02 23:12
End of day share price update: 2020/04/02 00:00
Last estimates confirmation: 2020/03/05
Last earnings filing: 2020/03/04
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.